Literature DB >> 32821545

Functional characterization of the chlorzoxazone 6-hydroxylation activity of human cytochrome P450 2E1 allelic variants in Han Chinese.

Ting Wang1, Huihui Du1, Jingsong Ma1, Lu Shen1, Muyun Wei1, Xianglong Zhao1, Luan Chen1, Mo Li1, Guorong Li2, Qinghe Xing3, Lin He1,4, Shengying Qin1,5.   

Abstract

BACKGROUNDS: Cytochrome P450 (P450) 2E1 is one of the primary enzymes responsible for the metabolism of xenobiotics, such as drugs and environmental carcinogens. The genetic polymorphisms of the CYP2E1 gene in promoter and coding regions have been identified previously in the Han Chinese population from four different geographic areas of Mainland China.
METHODS: To investigate whether genetic variants identified in the CYP2E1 coding region affect enzyme function, the enzymes of four single nucleotide polymorphism (SNP) variants in the coding region (novel c.1009C>T, causing p.Arg337X, where X represents the translational stop codon; c.227G>A, causing p.Arg76His; c.517G>A, yielding p.Gly173Ser; and c.1263C>T, presenting the highest allele frequency), two novel alleles (c.[227G>A;1263C>T] and c.[517G>A;1263C>T]), and the wild-type CYP2E1 were heterologously expressed in COS-7 cells and functionally characterized in terms of expression level and chlorzoxazone 6-hydroxylation activity. The impact of the CYP2E1 variant sequence on enzyme activity was predicted with three programs: Polyphen 2, PROVEAN and SIFT.
RESULTS: The prematurely terminated p.Arg337X variant enzyme was undetectable by western blotting and inactive toward chlorzoxazone 6-hydroxylation. The c.1263C>T and c.[517G>A;1263C>T] variant enzymes exhibited properties similar to those of the wild-type CYP2E1. The CYP2E1 variants c.227G>A and c.[227G>A;1263C>T] displayed significantly reduced enzyme activity relative to that of the wild-type enzyme (decreased by 42.8% and 32.8%, respectively; P < 0.01). The chlorzoxazone 6-hydroxylation activity of the c.517G>A transfectant was increased by 31% compared with the wild-type CYP2E1 enzyme (P < 0.01). Positive correlations were observed between the protein content and enzyme activity for CYP2E1 (P = 0.0005, r 2 = 0.8833). The characterization of enzyme function allelic variants in vitro was consistent with the potentially deleterious effect of the amino acid changes as determined by prediction tools.
CONCLUSIONS: These findings indicate that the genetic polymorphisms of CYP2E1, i.e., c.1009C>T (p.Arg337X), c.227G>A (p.Arg76His), and c.517G>A (p.Gly173Ser), could influence the metabolism of CYP2E1 substrates, such as chlorzoxazone. ©2020 Wang et al.

Entities:  

Keywords:  Chlorzoxazone; Enzyme activity; Genetic polymorphisms; Metabolism; Cytochrome P450 2E1 (CYP2E1)

Year:  2020        PMID: 32821545      PMCID: PMC7397980          DOI: 10.7717/peerj.9628

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  54 in total

Review 1.  Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.

Authors:  S Rendic; F J Di Carlo
Journal:  Drug Metab Rev       Date:  1997 Feb-May       Impact factor: 4.518

2.  Shape complementarity and hydrogen bond preferences in protein-protein interfaces: implications for antibody modeling and protein-protein docking.

Authors:  Daisuke Kuroda; Jeffrey J Gray
Journal:  Bioinformatics       Date:  2016-04-19       Impact factor: 6.937

3.  Genetic polymorphism of human CYP2E1: characterization of two variant alleles.

Authors:  Y Hu; M Oscarson; I Johansson; Q Y Yue; M L Dahl; M Tabone; S Arincò; E Albano; M Ingelman-Sundberg
Journal:  Mol Pharmacol       Date:  1997-03       Impact factor: 4.436

4.  Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population.

Authors:  Gulen Ulusoy; Emel Arinç; Orhan Adali
Journal:  Arch Toxicol       Date:  2007-03-23       Impact factor: 5.153

5.  Functional characterization of three human cytochrome p450 2E1 variants with amino acid substitutions.

Authors:  N Hanioka; T Tanaka-Kagawa; Y Miyata; E Matsushima; Y Makino; A Ohno; R Yoda; H Jinno; M Ando
Journal:  Xenobiotica       Date:  2003-06       Impact factor: 1.908

Review 6.  Pharmacogenomics: Precision Medicine and Drug Response.

Authors:  Richard M Weinshilboum; Liewei Wang
Journal:  Mayo Clin Proc       Date:  2017-11-01       Impact factor: 7.616

7.  CH-π hydrogen bonds in biological macromolecules.

Authors:  Motohiro Nishio; Yoji Umezawa; Jacques Fantini; Manfred S Weiss; Pinak Chakrabarti
Journal:  Phys Chem Chem Phys       Date:  2014-07-07       Impact factor: 3.676

8.  Detection and characterization of novel polymorphisms in the CYP2E1 gene.

Authors:  K S Fairbrother; J Grove; I de Waziers; D T Steimel; C P Day; C L Crespi; A K Daly
Journal:  Pharmacogenetics       Date:  1998-12

9.  Genetic polymorphism analysis of cytochrome P4502E1 (CYP2E1) in Chinese Han populations from four different geographic areas of Mainland China.

Authors:  Kefu Tang; Xin Li; Qinghe Xing; Weidong Li; Guoyin Feng; Lin He; Shengying Qin
Journal:  Genomics       Date:  2010-01-25       Impact factor: 5.736

10.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.

Authors:  Marco Biasini; Stefan Bienert; Andrew Waterhouse; Konstantin Arnold; Gabriel Studer; Tobias Schmidt; Florian Kiefer; Tiziano Gallo Cassarino; Martino Bertoni; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2014-04-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.